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Hedgehog (Hh) proteins signal by inhibiting the
proteolytic processing of Ci/Gli family tran-
scription factors and by increasing Ci/Gli-spe-
cific activity. When Hh is absent, phosphoryla-
tion of Ci/Gli triggers binding to SCF ubiquitin
ligase complexes and consequent proteolysis.
Here we show that multiple successively phos-
phorylated CK1 sites on Ci create an atypical
extended binding site for the SCF substrate
recognition component Slimb. GSK3 enhances
binding primarily through a nearby region of Ci,
which might contact an SCF component other
than Slimb. Studies of Ci variants with altered
CK1 and GSK3 sites suggest that the large
number of phosphorylation sites that direct
SCFSlimb binding confers a sensitive and graded
proteolytic response to Hh, which collaborates
with changes in Ci-specific activity to elicit
a morphogenetic response. We also show that
when Ci proteolysis is compromised, its spe-
cific activity is limited principally by Su(fu),
and not by Cos2 cytoplasmic tethering or PKA
phosphorylation.
INTRODUCTION
Drosophila Hedgehog (Hh) and its vertebrate homologs
are secreted signaling proteins that directly influence cell
fate and cell proliferation. Accordingly, severe develop-
mental abnormalities and multiple forms of cancer are
associated with genetic aberrations that alter the genera-
tion and transduction of Hh signals (McMahon et al., 2003;
Pasca di Magliano andHebrok, 2003). Cells respond to Hh
proteins primarily through altered transcription of specific
‘‘Hh target genes’’ that respond directly to Cubitus inter-
ruptus (Ci) in Drosophila and Gli-1/2/3 in vertebrates
(Hooper and Scott, 2005). In Drosophila, full-length Ci
(Ci-155) is proteolytically processed to a repressor form
(Ci-75) in the absence of Hh. Exposure of cells to Hh
inhibits Ci-155 processing, thereby increasing Ci-155Developmlevels while eliminating Ci-75 repressor, and also converts
Ci-155 into an effective transcriptional activator. In verte-
brates only Gli-2 andGli-3 are processed to shorter forms,
the latter of which provides most repressor function, while
Gli-2 and Gli-1 are the major sources of regulated activa-
tor function (Huangfu and Anderson, 2006).
Ci/Gli activator and repressor forms each have some
unique roles. For example, repressor forms have essential
roles in patterning vertebrate limb digits and in silencing
decapentaplegic (dpp) and hh expression in anterior
Drosophila wing disc cells, whereas induction of most Hh
target genes in the vertebrate neural tube and Drosophila
wing discs requires Ci/Gli activator function (Huangfu
and Anderson, 2006; Methot and Basler, 2001). However,
it is not known whether dose-dependent responses to Hh
proteins acting asmorphogens involvedifferent degreesof
Ci/Gli proteolysis, or if they depend on a collaboration
betweenchanges inCi/Gli proteolysis andspecific activity.
Proteolytic processing of Ci-155 to Ci-75 repressor is
relatively well understood in outline (Figure 1A) (Jiang,
2006). Ci-155 is phosphorylated at three Protein Kinase
A (PKA) sites. The resulting phosphoserines create recog-
nition sites for Glycogen Synthase Kinase 3 [GSK3; con-
sensus site, (S/T)xxx(Sp/Tp) and Casein Kinase 1 (CK1;
consensus site, (Sp/Tp)xx(S/T)], which propagate an ex-
tensive cascade of localized Ci-155 phosphorylation (Ilouz
et al., 2006; Jiang, 2006; Kobe et al., 2005). This creates
a binding site for Slimb, the homolog of vertebrate b-
TRCP, which is the key substrate recognition component
of an E3 Skp-1-Cullin-F-box (SCF) ubiquitin ligase com-
plex. Consequent proteasome digestion of ubiquitinated
Ci-155 appears to be arrested fairly efficiently by the sta-
ble folding of the Ci zinc finger domain coupled to the pro-
teolytic resistance of the adjacent polypeptide region,
thereby sparing the N-terminal Ci-75 polypeptide (Tian
et al., 2005). Similar mechanisms apply to Gli-2 and
Gli-3 proteins. In Drosophila, the Kinesin-related protein
Costal-2 (Cos2) binds Ci-155, PKA, CK1, and GSK3 to
facilitate Ci-155 phosphorylation. Partial dissociation of
those protein kinases from Cos2 is observed in response
to Hh and likely underlies the accompanying inhibition of
Ci-155 processing (Zhang et al., 2005).
Ci-155-specific activity is regulated by its binding part-
ners. Ci-155 is found largely in complexes containing
either Suppressor of fused [Su(fu)] or Cos2 (Hooper andental Cell 13, 481–495, October 2007 ª2007 Elsevier Inc. 481
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Regulation of Ci Proteolysis by PhosphorylationFigure 1. Identification of a Slimb Binding Site on Ci between PKA Sites 1 and 2
(A) Schematic showing the zinc finger (Zn) DNA-binding domain shared by Ci-155 and Ci-75, the phosphorylated region (Phos) depicted in (B) and (C),
and the region of Ci deleted in the Ci-U transgene. (B) Amino acids 834–899 of Ci showing the three (lightly boxed) groups of PKA sites (red, P1-P3),
PKA-primed GSK3 sites (green, G2 and G3), and PKA-primed CK1 sites (blue, C1–C3). Motifs resembling a consensus (DSGxxS) Slimb binding site
are underlined in purple. The four Ala substitutions of Ci-Ds2 andCi-Us3 (bracketed black dots) and residues deleted in Ci-D862-883 are indicated. (C)
Single Ala substituents tested in this study are indicated by residue number. The extended Slimb binding motif defined here is underlined (purple) and
arrows indicate critical consecutive CK1 (blue) and GSK3 (green) phosphorylations. Dashed underlining indicates residues of a potential weak Slimb
binding motif. (D) GST-Ci proteins with the named substitutions were phosphorylated by the indicated protein kinases and incubated with extracts of
Kc cells transfected with a Flag/HA-Slimb-Myc expression vector. Proteins brought down with glutathione beads were visualized on western blots
with HA antibody. In this and other figures, thick red boxes group single experiments that test GST-Ci variants relative to each other and a wild-type
(WT) control strictly in parallel. HA-Slimb band intensities were measured, corrected for background, and expressed relative to GST-Ci-WT with no
phosphorylation (fixed at 1.0) for that experiment. GST blots (not shown) confirm similar protein levels and similarly efficient phosphorylation, judged
by mobility shifts.Scott, 2005). These complexes are thought to restrain
Ci-155 activity in the absence of Hh because excess
Ci-155 can activate Hh target genes and both Cos2 and
Su(fu) can limit ectopic Hh target gene induction (Ingham
andMcMahon, 2001). However, it is not clear how the bur-
den of silencing Ci-155 is shared among these complexes.
Su(fu) appears to restrict both the nuclear entry and nu-
clear activity of Ci-155, whereas Cos2 limits Ci-155 nu-
clear import and promotes PKA-dependent Ci-155 prote-
olysis (Methot and Basler, 2000; Sisson et al., 2006; Wang
et al., 2000; Wang and Holmgren, 2000). Phosphorylation
of Ci-155 at the PKA sites that promote processing to
Ci-75 has also been suggested to reduce Ci-155-specific
activity (Wang et al., 1999). Hh promotes nuclear entry of482 Developmental Cell 13, 481–495, October 2007 ª2007 ElsCi-155, although the majority of Ci-155 still remains cyto-
plasmic. The protein kinase activity of Fused (Fu) is re-
quired to induce a full spectrum of Hh target genes, but
only if Su(fu) is present. Hence, Fu kinase activity is re-
quired principally to counter inhibition of Ci-155 by
Su(fu), even though Fu binds, and likely phosphorylates,
both Su(fu) and Cos2 (Hooper and Scott, 2005; Ingham
and McMahon, 2001).
Here we look at the mechanisms that regulate Ci-155
phosphorylation, proteolysis, and activity in greater detail
through in vitro phosphorylation and binding assays
coupled with activity assays in wing discs. In the wing
disc, Hh is produced in the posterior (P) compartment
and is secreted to anterior (A) cells, which express theevier Inc.
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Regulation of Ci Proteolysis by Phosphorylation12-pass transmembrane receptor, Patched (Ptc) and Ci.
Hh binding to Ptc relieves an inhibition on the 7-pass
transmembrane protein Smoothened (Smo), which is
essential for signal propagation. Specific target genes re-
spond to different concentrations of Hedgehog (Hooper
and Scott, 2005). Thus, dpp expression is induced in
a stripe of roughly a dozen cell widths extending from
the site of Hh expression, whereas ptc is induced in a nar-
rower domain, and engrailed (en), only in a few cells
exposed to the highest levels of Hh. Elevated Ci-155 levels
are seen over the whole range of Hh signaling at the ante-
rior-posterior (AP) border, suggesting that PKA-depen-
dent processing is inhibited even by low levels of Hh.
Within the AP border region, Ci-155 levels are in fact low-
est in the cells responding to the highest levels of Hh
because of a second proteolytic mechanism that uses
Cullin3 (Cul3) and an Hh-inducible protein to target Ci for
complete destruction (Jiang, 2006; Strigini and Cohen,
1997).
Previous studies established that binding of a Ci frag-
ment to Slimb in vitro is stimulated by PKA, CK1, and
GSK3 phosphorylation and depends on the primary
PKA, CK1, and GSK3 sites that are required for Ci-155
processing in vivo (Jia et al., 2005; Smelkinson and Kal-
deron, 2006). We now define a Slimb-binding site in Ci
generated by PKA and CK1 that differs from the canonical
b-TRCP/Slimb motif. We define a second region phos-
phorylated by PKA and GSK3 that enhances binding
only when Slimb assembles into an SCF complex, sug-
gesting the possibility of direct interaction with complex
components other than Slimb. We also uncover differing
requirements for CK1 and GSK3 in regulating Ci-155 pro-
cessing, provoking a model for sensitive, but potentially
graded, inhibition of Ci-155 proteolysis by Hh. Finally,
we show that PKA phosphorylation does not influence
Ci-155 activity beyond regulating its proteolysis, that
cytoplasmic retention of Ci-155 by Cos2 contributes little
to restraining Ci-155 activity, and that regulation of Ci-155
activity by Su(fu) and Fu depends critically on whether
Ci-155 is efficiently proteolyzed or not.
RESULTS
Ci Residues Directly Recognized by Slimb
Ci-Slimb binding was assayed previously by measuring
the amount of HA-tagged Slimb from Drosophila Kc cell
extracts that associated with immobilized GST-Ci685–920
proteins phosphorylated by purified kinases in vitro (Smel-
kinson and Kalderon, 2006). Binding was induced only
when GST-Ci was phosphorylated by both PKA and
CK1, and was increased further by GSK3. Substitution
of each of three PKA sites, both PKA-primed GSK3 sites
together, or all three PKA-primed CK1 sites together
(red, green, and blue, respectively, in Figures 1B and 1C)
reduced binding significantly (Smelkinson and Kalderon,
2006). However, it was not established whether those
phosphorylated residues bind to Slimb or are required
just to prime further phosphorylation by CK1 or GSK3.
To define which phosphorylated residues interact directlyDevelopmwith Slimb, we tested Ci variants with single amino acid
substitutions in each PKA-primed GSK3 and CK1 site
and in several potential CK1-primed CK1 sites (indicated
by numbered residues in Figure 1C).
Only two residues (T845 and S849) were found to be es-
sential for binding to Slimb (Figure 1D). Substitution of
S844 (adjacent to T845) also substantially reduced Slimb
binding, particularly in response to phosphorylation by
just PKA and CK1 (Figure 1D). If phosphorylated, S844,
T845, and S849 would contribute to a sequence,
SpTpYYGSp, that resembles the b-TRCP/Slimb binding
site consensus DSpGxxSp with respect to the three neg-
atively charged residues that are known to make key
binding contacts (Wu et al., 2003). Replacing S844 with
Asp in GST-Ci did not alter binding to Slimb significantly
(Figure 1D), suggesting that S844 functions as aphosphor-
ylated residue and that the Asp residue in the DSpGxxSp
consensus can be substituted by phosphoserine or phos-
phothreonine, as suggested previously (Eide et al., 2005;
Shirogane et al., 2005).
Any residue other than Gly at the third position of a con-
sensus b-TRCP binding site is expected to disrupt binding
substantially (Wu et al., 2003). When the Tyr residue at this
position in GST-Ci was substituted by Gly (Y846G), the
efficiency of phosphorylation of GST-Ci was unaltered,
but binding to Slimb was greatly increased in response
to PKA and CK1 (Figure 1D and Figure S2 in the Supple-
mental Data available with this article online). This indi-
cates that the SpTpYYGSp motif of GST-Ci binds less
well than a canonical DSpGxxSp peptide to Slimb, and
that PKA and CK1 suffice to phosphorylate this motif.
S849 is essential for binding to Slimb, but as summarized
in Figure 1C and justified below, S849 is not required to
prime any additional phosphorylation events in the pres-
ence of PKA, CK1, and GSK3. We therefore conclude
that Slimb-Ci association in vitro requires direct binding
of Slimb to the SpTpYYGSp motif of Ci.
The function of this motif was tested in vivo using
a transgene encoding full-length tagged Ci (Flag-HA-Ci-
Myc) with the S849A substitution. Proteolytic processing
of Ci variants to Ci-75 repressor can be assayed in poste-
rior wing disc cells, where endogenous ci is not expressed,
by preventing Hh signaling in smo mutant clones and
looking for repression of an hh-lacZ reporter gene (Methot
andBasler, 1999). In contrast to equivalently taggedCi-WT,
Ci-S849A failed to repress hh-lacZ in P smo mutant
clones, indicating that it cannot be converted to the Ci-75
repressor form (Figures S1A and S1B).
PKA Site 1 Primes CK1 to Generate a Slimb
Binding Site
Substitution of the GSK3 site primed by PKA site 2 (S852;
‘‘G2,’’ Figure 1C) with Ala eliminated Slimb binding in
response to just PKA and CK1 (S852A in Figure 1D). The
observation that S844, T845, S849, and S852 (G2) are all
required for Slimb binding stimulated by PKA and CK1
suggests that each of these residues can be phosphory-
lated by CK1 following PKA priming, even though S852
(G2) is clearly also a PKA-primed GSK3 site (Figure 1C).ental Cell 13, 481–495, October 2007 ª2007 Elsevier Inc. 483
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Regulation of Ci Proteolysis by PhosphorylationFigure 2. The Primary Slimb Binding Site of Ci Includes S852 (G2)
(A) Sequences of namedGST-Ci variants (left) between PKA sites 1 and 2 (red), highlighting inserted residues in pink, GSK3 sites primed by PKA site 2
in green, and S852 phosphorylated only by CK1 in blue. The core Slimb binding motif (black line) and S852 and PKA site 2 (arrows) are highlighted. (A
and D) Flag/HA-Slimb-Myc binding to GST-Ci variants, as in Figure 1. (B) Ci-SL has altered PKA sites 1 and 3 (P1A and P3A). PKA site 2 (red) primes
phosphorylation of three GSK3 sites (green) to create the Slimb/b-TRCP binding consensus of b-catenin. (C) Binding of phosphorylated GST-Ci-WT
and GST-Ci-SL to Flag/HA-Slimb-Myc-WT (Slimb-WT) or Flag/HA-Slimb(R333A/R353A)-Myc (Slimb-RA). Numbers show binding relative to Slimb-
WT (top row) or Slimb-RA (bottom row). Five percent of the extract used for each binding reaction is also shown.We confirmed this inference using an antibody raised
against a Ci peptide centered on phosphorylated S852
(CGSMQSpRRSSQS). We found that S852 could indeed
be phosphorylated either by GSK3 primed by PKA site 2
or by CK1 primed initially by PKA site 1 (Supplemental
Data and Figure S2). Furthermore, S852 phosphorylation
by CK1 required S849 (Figure S2), confirming the chain
of successive phosphorylation shown in Figure 1C. S844
and S852 are consensus (Sp/Tp)xx(S/T) CK1 sites,
whereas T845 and S849 fall within a variant CK1 consen-
sus, (Sp/Tp)xxx(S/T), that is used almost as efficiently
when assayed with peptide substrates in vitro (Bustos
et al., 2005; Kobe et al., 2005).
Ci Has an Extended Slimb Binding Site
S852 contributes to Slimb binding stimulated by PKA and
CK1, and might therefore be part of an extended Slimb-
binding sequence (Figure 1). We tested this hypothesis
by inserting five residues immediately preceding S852
(to form VQANLS; Figure 2A) to disrupt the motif while
preserving GSK3 phosphorylation of S852. We observed
complete loss of Slimb binding stimulated by PKA and
CK1 and greatly reduced binding in response to PKA,
CK1, and GSK3 together. Both defects were largely
remedied by replacing the first of the five inserted resi-
dues with Ser (in SQANL) to restore the putative extended
Slimb recognition motif, SpTpYYGSpMQSp (Figure 2A).
Similarly robust binding to Slimb was retained when this
motif was separated from PKA site 2 by as many as six484 Developmental Cell 13, 481–495, October 2007 ª2007 Elsenonpolar residues (in SQANLAFS) and was not increased
in this variant by introducing a Ser at a position analogous
to PKA site 2 (S852QANSAFS) (Figure 2A). In contrast,
substitution of S852 with Ala (to form A852QANSAFS)
greatly reduced binding to Slimb (Figure 2A), confirming
that S852 is part of an extended Slimb-binding motif
that retains function even when its position is altered rel-
ative to PKA site 2 and other, more C-terminal phosphor-
ylation sites.
We used the crystal structure of b-TRCP1/Skp-1 bound
to a dually phosphorylated b-catenin peptide (Wu et al.,
2003) to identify residues that might provide a favorable
electrostatic interaction with phosphorylated S852 and
substituted two such residues at a time in tagged Slimb
proteins used for GST-Ci binding experiments. The
R333A/R353A substitutions (Slimb-RA) eliminated stimu-
lation of GST-Ci binding by phosphorylation with PKA
and CK1 (Figure 2C), while the R310A/K356A substitu-
tions had no effect (data not shown). For comparison we
used a previously described GST-Ci-SL protein (Smelkin-
son and Kalderon, 2006), in which PKA site 2 primes
successive GSK3 phosphorylation events to produce
a prototypical b-TRCP/Slimb binding motif (DSpGIHSp)
identical to that of b-catenin (Figure 2B). This GST-Ci-SL
protein bound equally well to wild-type Slimb and Slimb-
RA after phosphorylation by PKA and GSK3 (Figure 2C).
Thus, binding to phosphorylatedGST-Ci involves residues
of Slimb that are not required to recognize the canonical
b-TRCP/Slimb substrate, b-catenin. We suggest thatvier Inc.
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Regulation of Ci Proteolysis by Phosphorylationone or both of the electropositive Slimb residues, R333
and R353, interact directly with phosphorylated S852.
To determine which feature of the binding site in Ci
allows interaction of an extended motif with Slimb, we
substituted S852 with Ala in the Y846G variant (to form
STGYGSMQA852; or Y846G G2A). This substitution had
no effect on the strong Slimb binding afforded by phos-
phorylation with PKA and CK1 (Figure 2D). Thus, the pres-
ence of Tyr rather thanGly at the third position of the Slimb
bindingmotif in Ci engenders a local peptide conformation
that allows favorable contacts of an additional phospho-
serine (S852 at position 9) with Slimb.
In summary, we have defined an essential, direct Slimb
binding site on Ci on the basis of a single amino acid sub-
stitution (S849A) that abolishes binding without affecting
further phosphorylation of Ci, and from the contributions
of neighboring phosphorylated residues, which form a lin-
ear sequencemotif with some resemblance to a canonical
Slimb/b-TRCP binding site. A key difference from canon-
ical motifs is the substitution of a critical Gly residue with
Tyr (Y846). This attenuates the interaction but allows Ci
to make use of an additional phosphorylated residue
(S852) within an extended binding motif. Full recognition
of the extended motif depends on Slimb residues (R333/
R353) that have not been implicated in binding to canon-
ical substrates.
GSK3 Enhances Slimb Binding via GSK3 Sites
Primed by PKA Site 3
Loss of either PKA site 3 (P3A; S891A/S892A) or the pre-
ceding GSK3 site (G3A; S888A) did not affect Slimb bind-
ing to GST-Ci phosphorylated only by PKA and CK1, but
more or less eliminated further stimulation of binding by
GSK3 (Figure 3A). Full-length Ci-G3A protein also accu-
mulated to abnormally high levels in anterior wing disc
cells, implying a significantly reduced rate of Ci-155
proteolysis (Figure 7; discussed later). Some processing
to Ci-75 was evident from the substantial repression of
hh-lacZ observed in posterior smo mutant clones of wing
discs expressing Ci-G3A (Figure S1D). These properties
of Ci-G3A are similar to those of wild-type Ci (Ci-WT) in
cells lacking shaggy GSK3 activity, where some process-
ing to Ci-75 persists (Figure S3A) despite a large increase
in Ci-155 levels (Jia et al., 2002; Price and Kalderon, 2002).
Thus, GSK3 acts principally through sites primed by PKA
site 3 to enhance Ci binding to Slimb and to ensure effi-
cient Ci-155 proteolysis in the absence of Hh signaling.
How does GSK3 enhance Ci-Slimb binding? G3 (S888)
phosphorylation can prime phosphorylation of another
GSK3 site (S884) (Figure 1C). Alteration of that site
(S884A) and a nearby acidic residue (D881A) reduced
the enhancement of Slimb binding by GSK3 without alter-
ing the binding induced by PKA andCK1 alone (Figure 3A).
The residue analogous to S884 in mammalian Gli-2 and
Gli-3 proteins is the seventh residue of a potential, variant
b-TRCP binding site (DSpYDPISp) (Figure 3A). The first
Ser in this motif is required for normal Gli-2 processing,
and the function of this motif in promoting Gli-3 process-
ing and b-TRCP association can be substituted for by aDevelopmcanonical b-TRCP binding motif, suggesting that this
Gli-2/3 motif binds directly to b-TRCP (Pan et al., 2006;
Tempe et al., 2006). The analogous sequence in Ci (SFYD-
PIS884) lacks an acidic or phosphorylatable residue at the
second position, and substitution of the first Ser (S878) to-
gether with the preceding three phosphorylatable resi-
dues (S872, S875, and T876) with Ala (to form Upstream
of site 3 [Us3]; Figure 1B) only marginally reduced Slimb
binding (Figure 3A). Moreover, S878 is not a consensus
site for PKA, CK1, or GSK3 and is therefore not expected
to be phosphorylated in our assays. Even removal of
amino acids 862 to 883 from GST-Ci (D862–883, Fig-
ure 1B) did not prevent reasonably strong PKA/CK1-
dependent binding to Slimb that was enhanced by
GSK3 (Figure 3A). Likewise, alteration of four putative
CK1 sites primed by PKA site 2 (Downstream of site 2
[Ds2], Figure 1B) did not significantly impair Ci-Slimb bind-
ing (Figure S4A). Thus, none of the phosphorylatable res-
idues between PKA site 2 and S884 (Figure 1) strongly
promotes Ci binding to Slimb in vitro.
To ascertain whether the apparently minimal role of the
S878FYDPIS884 motif in Ci resulted from a failure to phos-
phorylate S878 in vitro or from differences between the Ci
and Gli-2/3 motif, we converted S878 to a PKA site and
also changed the local Ci sequence to that of Gli-2/3
(DS879YDPIS884), while ensuring S879 phosphorylation
as a PKA-primedCK1 site (Figure S4B). Neither change in-
creased binding to Slimb, even though a consensus
DSGIHS884 motif introduced at the same position created
a strong Slimb binding site (Figure S4B). Thus, only the
third of the three critical electronegative residues of the
putative b-TRCP binding motif of Gli-2/3 (underlined in
DSpYDPISp) contributes significantly to Ci-Slimb binding,
and provision of all three did not enhance binding. We
therefore infer that GSK3 enhancement of Ci-Slimb bind-
ing is not mediated by a recognizable Slimb/b-TRCP bind-
ing motif and might not result from a direct interaction of
the critical phosphorylated GSK3 sites with Slimb.
Strong Ci Binding Requires SCF
Complex Assembly
We examined whether assembly of Slimb into SCF com-
plexes affected Ci binding. Slimb and b-TRCP proteins
can bind directly through their F-box domain to Skp-1
(SkpA in Drosophila), which binds directly to Cullin1
(Cul1) (Willems et al., 2004). Cul1 can bemodified by cova-
lent linkage to Nedd8 and associates with an Rbx/Roc
protein to form a complete SCF complex (Figure 3C). Sev-
eral F-box proteins can also form oligomers to generate
higher-order SCF complexes. In particular, b-TRCP pro-
teins dimerize through a D-domain preceding the F-box
domain (Suzuki et al., 2000).We expressed Flag/HA-Slimb
together with Myc-Slimb in Kc cells and observed robust
coimmune precipitation of Myc-Slimb with antibodies to
the Flag epitope, indicating abundant Slimb dimers or
higher-order oligomers (Figure 3B). Removal of the D-do-
main to form Flag/HA-Slimb-DD eliminated coprecipita-
tion of Myc-Slimb but Cul1 binding was retained, indicat-
ing SCF complex formation (Figure 3B). Flag/HA-Slimbental Cell 13, 481–495, October 2007 ª2007 Elsevier Inc. 485
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Regulation of Ci Proteolysis by PhosphorylationFigure 3. GSK3 Enhancement of Ci-Slimb Binding Requires GSK3 Sites Primed by PKA Site 3 and SCF Complex Formation
(A) GST-Ci variants binding to wild-type Flag/HA-Slimb-Myc probed with HA antibody. Also shown are relevant Ci and Gli-2/3 sequences.
(B) Western blots for the indicated antigens (right) of extracts of Kc cells expressing transfected Myc-Slimb and the indicated Flag/HA-Slimb
derivatives (top line) before or after immune precipitation with Flag antibody (Input and IP: Flag, respectively).
(C) Schematic of domains of Slimb and associated SCF complex proteins as a dimer bound to E2 enzymes. Folding of the two SCF complexes around
the D-D axis toward each other likely gives a more accurate representation (Tang et al., 2007).
(D and E) Binding of Flag/HA-Slimb-DD (D) or Flag/HA-Slimb-DF (E) expressed alone (upper panels) or together with Flag/HA-Slimb-WT (lower panels)
to GST-Ci and GST-Ci-SL assayed with Flag antibody (D) or HA antibody (E). Corrected band intensities are shown relative to SL-WT binding to
Ci-WT; for the lower panels, band intensities are also calculated relative to SL-DD or SL-DF binding to Ci-WT (bottom line).lacking the F-box domain coprecipitated Myc-Slimb as
efficiently as observed for wild-type Slimb, and also co-
precipitated a small amount of Cul1, presumably indirectly
via Myc-Slimb. Accordingly, Flag/HA-Slimb lacking both
the F-box and D-domain did not bind Cul1 at all.
We tested the binding properties of SCF complexes us-
ing extracts from Kc cells cotransfected with tagged
Slimb and tagged SkpA. SkpA bound to phosphorylated
GST-Ci with the same characteristics as Slimb (Fig-
ure S5A), as did endogenous Cul1 (Figure S5B). To test
if higher-order SCF complexes bind to GST-Ci, we first
constructed a Slimb variant that could not associate di-
rectly with substrate. This variant (Slimb-NB) showed
minimal phosphorylation-dependent binding to GST-Ci
(Figure S5C). However, coexpression of Myc-Slimb al-
lowed Flag/HA-Slimb-NB to associate with phosphory-
lated GST-Ci, presumably indirectly via Myc-Slimb
(Figure S5C). Thus, higher-order, likely dimeric, SCFSlimb
complexes can bind to GST-Ci.486 Developmental Cell 13, 481–495, October 2007 ª2007 ElseTo examine whether the cooperative binding afforded
by the CK1- and GSK3-phosphorylated regions of Ci
depends on simultaneous contacts with a higher-order
SCF complex, we used extracts expressing Slimbproteins
deficient for dimerization (Slimb-DD) or SCF complex as-
sembly (Slimb-DF). Slimb-DD bound as well as Slimb-WT
to the canonical DSpGIHSpmotif of GST-Ci-SL phosphor-
ylated by PKA and GSK3, but less well (by roughly 5-fold)
than Slimb-WT to GST-Ci-WT (Figure 3D). Nevertheless,
PKA/CK1-stimulated binding of Slimb-DD to GST-Ci was
still enhanced by GSK3 (Figure 3D). Thus, the two phos-
phorylated regions of Ci can cooperate to bind Slimb
even if dimeric or higher-order SCF complexes cannot
form.
Slimb-DF bound less efficiently than Slimb-WT to GST-
Ci in response to PKA and CK1, consistent with a role
for intact SCF dimers (or oligomers) in strong Ci binding.
Strikingly, however, GSK3 phosphorylation of GST-Ci-WT
did not enhance binding to Slimb-DF (Figure 3E). Thus,vier Inc.
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Regulation of Ci Proteolysis by PhosphorylationGSK3-stimulated binding is evident only for Slimb that is
assembled into an SCF complex. This suggests that
GSK3 may regulate Ci primarily through the creation of
a binding site for an SCF component other than Slimb.
Regulation of Ci-155 Proteolysis via CK1
and GSK3
The association of PKA, CK1, and GSK3 with Cos2 facili-
tates Ci-155 phosphorylation and processing in Drosoph-
ila wing discs, and is reduced in response to Hh, implying
that kinase dissociation from Cos2 might be instrumental
in the stabilization of Ci-155 by Hh (Zhang et al., 2005). We
used Ci variants to test if the regulation of Ci-155 process-
ing by Hh requires the participation of both CK1 and
GSK3. GST-Ci-G2,3E has Glu substituents at both PKA-
primed GSK3 sites and the one GSK3-primed GSK3 site
(S852E/S884E/S888E); its binding to Slimb in vitro is stim-
ulated by PKA and CK1, but not by GSK3 (Smelkinson and
Kalderon, 2006). Ci-G2,3E is processed toCi-75 repressor
in posterior smo mutant wing disc clones, where Hh sig-
naling is blocked, but hh-lacZ is strongly expressed in sur-
rounding tissue, indicating substantial inhibition of pro-
cessing by Hh (Smelkinson and Kalderon, 2006). To test
more sensitively for any residual processing in cells under-
going Hh signaling, we expressed Ci-G2,3E and Ci-WT in
positively marked P wing disc clones that retain normal
Smo function. We did not observe any hh-lacZ repression
in such clones (Figures 4A and 4B), implying that Hh in-
hibits Ci-155 proteolysis efficiently even when there is no
regulation of Ci phosphorylation at its critical GSK3 sites.
The binding of GST-Ci-SL to Slimb in vitro depends only
on phosphorylation by PKA andGSK3 (Figures 2B and 2C)
(Smelkinson and Kalderon, 2006). Ci-SL is processed to
Ci-75 repressor in P smo mutant clones, whereas strong
hh-lacZ expression was evident in surrounding P wing
disc tissue, indicating substantial inhibition of Ci-155
processing by Hh signaling (Smelkinson and Kalderon,
2006). However, positively marked clones expressing
Ci-SL in otherwise WT wing discs exhibited significant
repression of hh-lacZ (Figure 4C). Thus, Hh signaling does
not completely inhibit the processing of Ci-SL, which is
driven by only PKA and GSK3 phosphorylation.
SinceGST-Ci-SL binds slightly more strongly thanGST-
Ci-WT to Slimb in vitro, we explored whether the failure of
Hh to inhibit Ci-SL processing completely might be due to
a stronger Ci-Slimb interaction rather than to the specific
protein kinases driving proteolysis. Ci-Y846G binding to
Slimb in vitro is even stronger than that observed for
Ci-WT or Ci-SL and depends on phosphorylation by only
PKA and CK1 (Figure 1D and Figure 2D). However, no
hh-lacZ repression was observed in clones that expressed
Ci-Y846G in the presence of Hh (Figure 4D). This confirms
the conclusion (from Ci-G2,3E) that GSK3 participation is
not essential for Hh to block Ci-155 processing efficiently
and indicates that the failure of Hh to block Ci-SL process-
ing completely is because CK1 does not participate.
Increased affinity of phosphorylated Ci for Slimb (as for
Ci-Y846G) does not cause constitutive processing of
Ci-155 to Ci-75 in the presence of Hh.DevelopmPKA-Dependent Proteolysis of Ci-U Invalidates
the Prior Conclusion that PKA Sites 1–3 Regulate
Ci-155-Specific Activity
Having learned more about the mechanisms of Ci phos-
phorylation and proteolysis, we explored further how
these regulatory influences affect Ci activity in vivo. Ci-155
levels are increased substantially and Ci-75 repressor ac-
tivity is undetectable in both slimb and pka mutant wing
disc clones, but only the latter induce the Hh target gene
reporter ptc-lacZ and En (Ingham and McMahon, 2001)
(Figures S6A–S6J) Furthermore, ptc-lacZ is induced in
slimb mutant clones that express a PKA inhibitor (Wang
et al., 1999) and in slimb pka double mutant clones (Fig-
ures S6K–S6T), suggesting that the specific activity of
Ci-155 might be reduced by direct PKA phosphorylation.
This idea was tested previously using a Ci derivative
lacking amino acids 611–760 (Ci-U; Figure 1A) that was
thought to be resistant to PKA-dependent proteolysis be-
cause it could not be processed to the Ci-75 repressor
(Methot and Basler, 1999). Expression of Ci-U throughout
the wing disc induced ectopic ptc-lacZ only in posterior
cells where Hh is present, whereas a Ci-U derivative lack-
ing PKA sites 1–3 induced ptc-lacZ also in anterior cells
that are not exposed to Hh (Wang et al., 1999). It was con-
cluded that phosphorylation of PKA sites 1–3 reduces the
specific activity of Ci-U in A wing disc cells. However, it
was recently proposed that exactly those sequences ab-
sent from Ci-U collaborate with the zinc finger region of
wild-type Ci to arrest digestion of ubiquitinated Ci-155
by the proteasome in order to spare the N-terminal
Ci-75 repressor derivative (Tian et al., 2005). Thus, Ci-U
may be defective for processing to Ci-75 but not for
PKA-dependent ubiquitination and consequent complete
proteolysis by the proteasome. We therefore re-examined
Figure 4. Hh Only Fully Blocks Ci-155 Processing if CK1 Reg-
ulates Slimb Binding
(A–D) Conversion of Ci-155 to Ci-75 repressor was assayed in posi-
tively marked wing disc clones that lack GAL80 and therefore express
the indicated Ci variants together with GFP (green). Reduced expres-
sion of hh-lacZ (red) in posterior cells (right), indicating Ci-75 repressor,
was seen for Ci-SL (C, arrow), especially outside the central wing blade
primordia (C, arrowhead), but not for Ci-WT (A, open arrowheads),
Ci-G2,3E (B), or Ci-Y846G (D).ental Cell 13, 481–495, October 2007 ª2007 Elsevier Inc. 487
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terminus.
A UAS-Flag/HA-Ci-U-Myc transgene was expressed
evenly throughout the wing disc using C765-GAL4 and,
as previously reported, induced ectopic ptc-lacZ only in
P cells (Figure 5B) and largely failed to repress hh-lacZ
in P smo mutant clones, indicating deficient processing
to Ci-75 (Figure S3B). However, staining for a C-terminal
Myc epitope showed that full-length Ci-U protein levels
were higher in P cells, where Hh is present, than in A cells
that are not exposed to Hh (Figure S7B). Furthermore, full-
length Ci-U levels were reduced in P smo mutant clones,
where Hh signaling is blocked (Figure S7H); levels were
also elevated in A smo pka double mutant clones, where
PKA phosphorylation of Ci-U is blocked (Figure S7K).
Thus, Ci-U appears to be proteolyzed in a PKA-dependent
(and Hh-regulated) manner, just as that seen for wild-type
Ci (Figures S7A, S7G, and S7J). Hence, the activation of
Hh target genes in A cells of wing discs that was previously
observed when Ala residues replaced PKA sites 1–3 of
Ci-U is likely attributable, at least in part, to stabilization
of Ci-U, and certainly cannot be taken as evidence of
increased Ci-U-specific activity.
Figure 5. Su(fu) and Fu Kinase Regulate the Activity of Prote-
olysis-Resistant Ci-155
(A) Ectopic induction of ptc-lacZ (blue; assayed by b-galactosidase
activity) by ci transgenes driven by C765-GAL4 was seen only in pos-
terior wing disc cells (right) for Ci-WT at 29C and 20C but was also
seen in anterior cells for Ci-S849A at 29C. At 20C, Ci-S849A induced
anterior ptc-lacZ only when Su(fu) was absent.
(B) Selective induction of ptc-lacZ (red; detected by antibody to b-
galactosidase) in posterior cells (right) by Ci-S849A and Ci-P1-3A
expressed at 20C using C765-GAL4 was eliminated in fumH63 wing
discs lacking Fu kinase activity but was merely reduced in discs
expressing Ci-WT (here at 20C) or Ci-U (here at 29C).488 Developmental Cell 13, 481–495, October 2007 ª2007 ElsePKA Regulates Ci-155 Activity by Affecting Ci-155
Levels but Not Ci-155-Specific Activity
From our studies of GST-Ci phosphorylation and Slimb
binding in vitro, we expected Ci-S849A to be completely
refractory to PKA-dependent proteolysis but susceptible
to phosphorylation at all residues other than S849. Uni-
form transcription of a Ci-S849A transgene in wing discs
resulted in full-length Ci-S849A protein levels, detected
by a C-terminal Myc epitope, that were slightly higher in
A cells than in Hh-expressing P cells (Figure S7C), as
expected for a Ci variant that is subject only to Hh-stimu-
lated, Cul3-dependent proteolysis (Jiang, 2006). When
Cul3-dependent proteolysis was eliminated by using
wing discs that lack Fu kinase activity, Ci-S849-Myc levels
were equal in A and P cells, whereas Ci-WT-Myc and
Ci-U-Myc levels were clearly higher in P cells (Figures
S7D–S7F). Ci-S849A Myc epitope levels were neither de-
creased in P smomutant clones (Figure S7I) nor increased
in A smo pka double mutant clones (Figure S7L), confirm-
ing that Ci-S849A is not subject to PKA-dependent prote-
olysis or regulation of this proteolysis by Hh. Ci-P1-3A has
Ala substitutions at PKA sites 1–3 (Price and Kalderon,
2002) and is also completely refractory to PKA-dependent
proteolysis, exhibiting the same C-terminal Myc epitope
staining patterns as described above for Ci-S849A (data
not shown). Comparison of Ci-S849A and Ci-P1-3A can
therefore reveal whether any effects of PKA on Ci-155-
specific activity involve PKA sites 1–3.
Ci-S849A and Ci-P1-3A transgenes consistently in-
duced ectopic ptc-lacZ in both A and P cells, whereas
Ci-WT induced ectopic ptc-lacZ only in P cells when the
transgenes were expressed using C765-GAL4 and as-
sayed at 25C or 29C (Figure 5A and data not shown).
Thus, in contrast to conclusions drawn previously from
the properties of Ci-U (Methot and Basler, 1999), resis-
tance to proteolysis can suffice for Ci-155 to activate
the prototypical Hh target gene, ptc. This presumably
results simply from the increased levels of proteolysis-
resistant Ci-155.
If assayed at 20C, at which temperature GAL4 activity
is roughly 4-fold lower than at 29C (Morimura et al., 1996),
Ci-S849A and Ci-P1-3A transgenes induced ectopic ptc-
lacZ almost exclusively in P cells (Figures 5A and 5B), and
did so only when those cells retained smo function (Fig-
ures 6D and 6G), indicating Hh-dependent activity. Thus,
at 20C, Ci-S849A and Ci-P1-3A do not quite accumulate
sufficiently to escape inhibition by stoichiometric binding
partners in the absence of Hh signaling, but should be
poised to induce ptc-lacZ in response to any increase in
Ci-155-specific activity. However, we saw no increase in
ptc-lacZ expression in P smo pka clones compared with
P smo mutant clones in wing discs expressing either
Ci-S849A or Ci-P1-3A at 20C (Figures 6D, 6E, 6G, and
6H). We conclude that the activity of proteolysis-resistant
Ci-155 is not significantly constrained by direct PKA phos-
phorylation in the absence of Hh signaling. By contrast,
Ci-WT and Ci-U transgenes induced higher levels of ptc-
lacZ in P smo pka double mutant clones than in P smo
mutant clones at both 20C and 29C (Figures 6A andvier Inc.
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(A–I) Activation of the ptc-lacZ reporter (red) by Ci-WT (A–C), Ci-S849A (D–F), and Ci-P1-3A (G–I) expressed usingC765-GAL4 at 20Cwas compared
in posterior clones (arrowheads), marked by loss of GFP (green), that lacked activity of Smo alone (A, D, and G) or Smo together with either PKA (B, E,
andH) or Cos2 (C, F, and I). ptc-lacZ induction was increased by the additional loss of PKA andCos2 for Ci-WT (B andC versus A) but not for Ci-S849A
(D–F) or Ci-P1-3A (G–I).6B; data not shown). This induction presumably results
entirely from the stabilization of Ci-155.
Factors that Regulate the Activity
of Stabilized Ci-155
In the absence of Hh, Cos2 is thought to facilitate PKA-
dependent Ci-155 proteolysis and to limit Ci-155 activity
also by reducing nuclear import of Ci-155 (Wang et al.,
2000; Wang and Holmgren, 2000). These two proposed
activities have not, however, been uncoupled to assess
each individual contribution. We found that Ci-S849A
and Ci-P1-3A did not induce significantly higher levels of
ptc-lacZ at 20C in P smo cos2 double mutant clones
than in smo mutant clones (Figures 6F and 6I). Thus, for
the levels of proteolysis-resistant Ci-155 in this assay,
Cos2 does not significantly limit Ci-155 activity by cyto-
plasmic tethering or any other mechanism. We tested
the validity of this conclusion under normal conditions of
ci expression by comparing the phenotypes of pka cos2
double mutant clones with single pka and cos2 mutant
clones in otherwise normal wing discs. Loss of Cos2 func-
tion in anterior clones induces high levels of Ci-155 and
ptc-lacZ but almost no ectopic expression of Engrailed
(En), which responds only to high levels of Hh pathway
activity (Ingham and McMahon, 2001) (Figure S8B). pka
mutant clones induce strong ectopic ptc-lacZ and clear
ectopic En expression, albeit weaker than Hh-indepen-
dent En expression in P cells and Hh-induced En
expression in AP border cells (Figure S8A). These differentDevelopmphenotypes are somewhat surprising in view of the fact
that nuclear accumulation of Ci-155 is more rapid in
cos2 than in pka mutant cells of wing discs treated with
Leptomycin B to inhibit nuclear export (Wang et al.,
2000; Wang and Holmgren, 2000). However, since inhibi-
tion of Ci-155 proteolysis might be less complete in cos2
than in pka mutant clones, we also examined pka cos2
double mutant clones, in which Ci-155 levels should be
equivalent to those in pka mutant clones. Ectopic En ex-
pression was induced in pka cos2 double mutant clones
to the same level as that observed in pka mutant clones,
but no greater (Figure S8C). Thus, in the absence of PKA
phosphorylation and consequent proteolysis, endoge-
nous Ci-155 activity is not significantly restrained byCos2.
Cos2 also has a role in transducing an Hh signal, but un-
covering evidence for this activity in wing discs has been
limited to assaying high-level Hh target genes (Wang
et al., 2000; Wang and Holmgren, 2000) because other
target genes, like ptc, are induced simply by eliminating
the inhibitory action of Cos2 on Ci. Since Cos2 does not
significantly limit the activity of Ci-S849A at 20C in the
absence of Hh signaling, we were able to test the positive
role of Cos2 in cells responding to Hh in isolation. Loss
of Cos2 activity in P wing disc clones reduced Hh-depen-
dent induction of ptc-lacZ by Ci-S849A to a similar extent
as that seen in smo mutant clones (Figure S9). This is
consistent with the possibility that Cos2 might be neces-
sary to transduce all aspects of the Hh response (Lum
et al., 2003).ental Cell 13, 481–495, October 2007 ª2007 Elsevier Inc. 489
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Su(fu) activity resulted in the induction of ptc-lacZ in A
cells to almost the same level as in Hh-responding P and
AP border cells (Figure 5A). By contrast, Ci-WT did not
induce ptc-lacZ expression in A cells in the absence of
Su(fu), even at 29C (Figure 5A). These observations indi-
cate that Su(fu) is the key factor that limits the activity of
Ci-155 that is protected from PKA-dependent proteolysis.
Fu kinase activity is required for Hh to counter the inhib-
itory action of Su(fu) on Ci-155 (Ingham and McMahon,
2001). Accordingly, in wing discs lacking Fu kinase activ-
ity, Ci-S849A and Ci-P1-3A induced almost no ptc-lacZ
expression in P cells at 20C (Figure 5B). Induction of
ptc-lacZ in P cells by Ci-WT and Ci-U was also reduced
by loss of Fu kinase activity, but remained greater than
in A cells, especially at higher temperatures, presumably
because of selective stabilization of full-length Ci in P cells
(Figure 5B). Altogether, these observations indicate that
PKA-dependent proteolysis normally suffices to silence
Ci-155 in A wing disc cells without any requirement for
Su(fu), whereas complete inhibition of PKA-dependent
proteolysis raises endogenous Ci-155 levels to a level
just beyond the silencing capacity of Su(fu).
In summary, we have used proteolysis-resistant Ci
variants to establish that PKA and Cos2 limit Ci activity
principally by regulating its proteolysis, and that only
Su(fu) significantly restrains full-length Ci activity indepen-
dent of proteolysis.
The Efficiency of Ci-155 Proteolysis Influences
Hh Target Gene Induction
To investigate the consequences of reducing, rather than
eliminating, phosphorylation-stimulated binding of Ci to
SCFSlimb, we assayed the properties of a number of variant
ci transgenes expressed at 29C using C765-GAL4 in
wing discs. We chose those conditions to enable an
approximation, or a slight excess, of the expression level
of endogenous ci in anterior wing disc cells (based on in-
duction of ptc-lacZ by endogenous Ci in pka, but not slimb,
mutant clones and by Ci-S849A at 29C, but not 20C).
Ci-G3A (S888A), Ci-G2,3E (S852E/S844E/S888E), and
Ci-SRRAS (S855A/S891A), which exhibited 2- to 5-fold re-
ductions in Slimb binding in vitro, substantially repressed
hh-lacZ in P smo mutant clones (Smelkinson and Kal-
deron, 2006) (Figure 3 and Figure S1 and Figure S4), but
exhibited greater C-terminal Myc epitope staining in A
cells than P cells, indicating inefficient proteolysis in vivo
(Figure 7). Aberrantly high anterior levels of Ci-155 cou-
pled to strong hh-lacZ repression in P smo clones has
also been seen for Ci-SL, which bound Slimb at least as
strongly as wild-type Ci in vitro (but may not be phosphor-
ylated as efficiently in vivo), and for endogenous Ci in cells
either lacking GSK3 activity or exhibiting compromised
SCF function due to Nedd8 inactivation (Ou et al., 2002;
Smelkinson and Kalderon, 2006) (Figure S3). Thus, the
hh-lacZ assay detects even low levels of processing,
whereas staining for full-length Ci easily detects reduc-
tions in proteolytic efficiency. More importantly, 2- to 5-
fold reductions in our in vitro Slimb binding assay reflect490 Developmental Cell 13, 481–495, October 2007 ª2007 Elschanges in affinity in vivo that substantially inhibit Ci-155
proteolysis.
Under the conditions of our assay, where endogenous
Ci is supplemented by a Ci variant expressed at a slightly
greater level, Ci-G3A, Ci-G2,3E, and Ci-SRRAS induced
ectopic anterior ptc-lacZ expression in all lines (Figure 7).
Ci-Us3 and Ci-Ds2 (Figure 1B), which had only minimal
Slimb-binding deficits in vitro (Figure 3 and Figure S4)
and fully repressed hh-lacZ in P smo mutant clones
(Figure S1), exhibited abnormally intense anterior C-termi-
nal Myc epitope staining in some lines, but not others (Fig-
ure 7), presumably becausemarginally compromised pro-
teolysis was overwhelmed only in lines where transgene
expression was greater. The resulting increase in anterior
Ci-155 levels was sufficient to induce anterior ptc-lacZ in
some Ci-Ds2 lines, but not in any Ci-Us3 lines (Figure 7).
These results show that small differences in Ci-155 levels
that are not readily detected by direct staining can deter-
mine whether ptc is induced or not.
We cannot predict from these experiments whether
the impairment of proteolysis in variants such as Ci-G3A
would suffice to induce ectopic ptc in anterior wing disc
cells if expressed alone and at exactly the same level as
endogenous ci. However, we do surmise that the resulting
Ci-155 levels would be close to the threshold for ptc
induction and might readily cross that threshold in re-
sponse to a small increase in Ci-155-specific activity.
Similarly, in pka mutant clones, complete disruption of
PKA-dependent Ci-155 proteolysis suffices for activation
of ptc, but an increase in Ci-155-specific activity is also
required to induce en strongly (Figure S6).
DISCUSSION
Regulation of Ci-155-Specific Activity
The central task of Hh signal transduction in Drosophila is
to regulate the activity of the transcription factor Ci. This is
accomplished by regulating the levels of Ci-155 activator
and Ci-75 repressor and the specific activity of Ci-155.
To examine the regulation of Ci-155-specific activity in iso-
lation, we developed a Ci variant (Ci-S849A) that escapes
PKA-dependent proteolysis but has a minimally altered
pattern of PKA-initiated phosphorylation. At 29C, Ci-
S849A was expressed in wing discs (via C765-GAL4) at
roughly the same level as endogenous Ci, but at 20C,
the levels of Ci-S849A were distinctly lower. At 29C,
Ci-S849A induced the Hh target gene reporter ptc-lacZ
in A cells that are not stimulated byHh. Since ptc induction
requires Ci-155 activator and is not accomplished simply
by loss of Ci-75 repressor (Methot and Basler, 1999), we
conclude that elevated levels of Ci-155 can suffice to con-
fer some activator function. At 20C, Ci-S849A induced
ptc-lacZ in A cells only when Su(fu) was removed. By con-
trast, Ci-S849A activity was not detectably increased by
loss of either PKA activity or Cos2 activity in P smomutant
clones, where Hh signaling is blocked. Thus, Su(fu) is the
principal component that limits Ci-155-specific activity
when Ci-155 is protected from PKA-dependentevier Inc.
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C-terminal Myc epitope staining (red) of Ci variants expressed at 29C using C765-GAL4was greatest in posterior cells (right) only for Ci-Y846G and
some Ci-Us3 and Ci-Ds2 lines. The inferred inefficient proteolysis of Ci-155 in other lines was accompanied in every case (except for one Ci-Us3 line)
by ectopic induction of anterior ptc-lacZ (blue), assayed by b-galactosidase activity. ‘‘G2,3E’’ is S852E/S888E and ‘‘SRRAS’’ is S855A/S891A. Results
of Ci-75 repressor assays (hh-lacZ repression) and Slimb binding assays (expressed as a percentage of wild-type Ci binding after phosphorylation
with PKA, CK1, and GSK3) are also tabulated for each Ci variant.proteolysis, whereas PKA and Cos2 normally limit Ci-155
activity simply by promoting its proteolysis.
The prior assertion that PKA limits Ci-155-specific activ-
ity by direct phosphorylation was based on the use of an
inappropriate reagent (Ci-U), which was mistakenly
thought to be inert to PKA-dependent proteolysis (Wang
et al., 1999). A similar role for Cos2 was previously inferred
principally from the observation that Ci-155 accumulated
more rapidly in the nuclei of anterior Leptomycin B-treated
wing disc cells when those cells lack Cos2 activity (Wang
et al., 2000; Wang and Holmgren, 2000). It appears that
the inferred cytoplasmic retention of Ci-155 by Cos2 con-
tributes very little quantitatively to limiting the activity of
stabilized Ci-155. That conclusion is supported by our
observation that loss of Cos2 function did not enhance
the weak induction of En seen in pka mutant clones of
otherwise WT wing discs. The remaining, long-standing
observations suggesting roles for PKA andCos2 in limiting
Ci-155-specific activity are the different degrees of Hh
target gene induction in pka (strongest), cos2 (intermedi-
ate), and slimb (weakest) mutant wing disc clones. We
suggest that thismight result fromdifferent degrees of dis-
ruption of PKA-dependent proteolysis in these clones.
This suggestion is consistent with the proposed role of
Cos2 in facilitating Ci-155 phosphorylation (Zhang et al.,
2005) and with our observation that ptc-lacZ can be in-
duced in slimbmutant clones when PKA activity is halved
(Figure S6).
Regulation of Ci-155 Activity through Inhibition
of PKA-Dependent Proteolysis
We have found that both GST-Ci association with
SCFSlimb and Ci-155 proteolysis depend on two phos-
phorylated regions of Ci. The first region provides anDevelopmessential Slimb binding site that can be created by five
successive CK1 phosphorylations primed initially by
PKA site 1. Of the four phosphorylated residues within
the motif (844SpTpYYGSpMQSp852) that interacts directly
with Slimb, at least one (S849) is essential for binding, and
two others (S844 and S852) enhance binding (T845 is es-
sential, but priming and binding functions have not been
separated). The second critical phosphorylated region of
Ci includes two GSK3 sites (S884 and S888) that are
primed by PKA site 3. This region enhances, but is not
sufficient for, binding to SCFSlimb.
The requirement for multiple successive phosphoryla-
tions by PKA, CK1, and GSK3 to create a high-affinity
SCFSlimb binding domain on Ci-155 has two important
consequences. First, it demands a special mechanism
for facilitating Ci phosphorylation that is met by Cos2.
Second, it provides a mechanism through which a small
change in Ci-155 phosphorylation, induced for example
by limited dissociation of protein kinases from Cos2, can
be translated into a substantial inhibition of Ci-155 prote-
olysis. The sharp increase in Ci-155 levels at the anterior
limit of Hh signaling territory shows that a low dose of
Hh does indeed severely curtail PKA-dependent Ci-155
proteolysis (Hooper and Scott, 2005). We found that Hh
could inhibit proteolytic processing of Ci variants driven
by either PKA-primed GSK3 sites (Ci-SL) or PKA-primed
CK1 sites (Ci-G2,3E and Ci-Y846G), but complete inhibi-
tion was observed only for the latter pair. This suggests
that the sensitive response of Ci proteolysis to Hh
depends principally on CK1.
How does inhibition of Ci-155 proteolysis affect Ci-155
activity? Previously, the properties of Ci-U and slimb
mutant clones were taken as evidence that inhibition of
proteolysis does not suffice for Ci activation. Since weental Cell 13, 481–495, October 2007 ª2007 Elsevier Inc. 491
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proteolysis and that PKA does not affect the specific activ-
ity of Ci-155, we rely instead on the properties of Ci-S849A
and pka mutant clones to conclude that complete inhibi-
tion of PKA-dependent proteolysis does suffice to induce
the Hh target gene ptc. This, in turn, suggests that the high
Ci-155 levels anterior to the stripe of elevated ptc expres-
sion at the AP border of wing discs result from substantial,
but incomplete, inhibition of Ci-155 proteolysis.
It has generally been assumed that inhibition of Ci-155
proteolysis is uniformly strong throughout the AP border
and that the activation of ptc and en in nested domains
is due solely to changes in Ci-155-specific activity elicited
by increasing levels of Hh. However, several factors sug-
gest to us that there may also be a significant gradient
of residual PKA-dependent proteolysis at the AP border
that contributes to morphogen action.
First, the precise degree of substantially inhibitedCi-155
proteolysis can determine whether Hh target genes are
induced or not. This is evident from differences in ptc-
lacZ induction among proteolytically impaired Ci variants
(Figure 7) and between pka and slimbmutant clones.
Second, we have found that Su(fu) is the principal regu-
lator of Ci-155 activity when Ci-155 levels are elevated,
yet Hh instructs an almost unchanged morphogenetic
response in the absence of Su(fu). It is likely that a proteo-
lytic gradient is critical under these conditions, although
it is also possible that Cos2 assumes a more significant
role in regulating Ci-155-specific activity when Su(fu) is
absent.
Third, we found that the loss of any one of four phospho-
serines that contribute to Ci-Slimb binding (S844, S852,
S884, and S888) diminishes, but does not abolish, Slimb
binding. For S888A (G3A) this results in elevated Ci-155
levels and an increased activity, but residual proteolysis
is clearly evident from the generation of sufficient Ci-75
to repress hh-lacZ (Figure S1D and Figure 7). Thus, disper-
sion of direct Slimb binding determinants among several
phosphorylatable residues provides a mechanism for Hh
to elicit graded inhibition of Ci-155 proteolysis. We spec-
ulate that in response to high levels of Hh, most Ci-155
molecules will not bind to SCFSlimb at all because they
lack at least two of the six key phosphorylated residues,
whereas a large proportion of Ci-155 molecules may
bind SCFSlimb with intermediate affinity in response to
low or intermediate Hh levels because they lack only one
critical phosphoserine.
Fourth, regulation of Ci-155-specific activity depends
on Ci-155 levels. Thus, Ci-155 is only activated by loss
of Su(fu) when Ci-155 levels are elevated by Hh or appro-
priate mutations, presumably because other stoichio-
metric binding partners such as Cos2 act redundantly
with Su(fu) when their Ci-155 binding capacity is not satu-
rated. We would therefore expect the release of Ci-155
from repressive partners to be progressively facilitated
as the relative levels of Ci-155 increase. This would allow
increasing Hh levels to enhance Ci-155 activity through
synergistic effects on Ci-155 levels and Ci-155-specific
activity.492 Developmental Cell 13, 481–495, October 2007 ª2007 ElseProperties of a Variant Slimb/b-TRCP
Binding Motif
The archetypal b-TRCP/Slimb substrates, b-catenin and
IKB, contain a single, dually phosphorylated, high-affinity
binding site (DSpGxxSp) that triggers rapid substrate pro-
teolysis (Willems et al., 2004). The primary direct Slimb
binding motif that we defined (SpTpYYGSpMQSp) in Ci
differs notably by the presence of Tyr instead of Gly at
the third position, by the inclusion of a fourth electronega-
tive residue at its C terminus, and by binding with lower
affinity, permitting additional influences on Ci-SCFSlimb
association. The fourth electronegative residue (pS852)
likely interacts with at least one of two positively charged
Slimb surface residues (R333 and R353) based on their
potential proximity and reduced GST-Ci binding to the
R333A/R353A Slimb variant.
Most known b-TRCP substrates include phosphory-
lated or acidic residues that are two to four residues
C-terminal to the standard six amino acid binding motif
(DSpGXXSp), but their contribution to binding has not
generally been assessed. Even b-catenin includes such
phosphorylated residues that are known to have an es-
sential priming role but have not been tested rigorously
for direct interactions with b-TRCP. The variant b-TRCP
binding motif (EEGFGSpSSp) of mammalian Wee1A pres-
ents a notable exception, in which a b-TRCP Arg residue
equivalent to R353 of Slimb interacts with the phospho-
serines at position 6 and 8 of this motif (Watanabe et al.,
2005). This suggests that positive surface residues of
b-TRCP/Slimb may commonly stabilize association with
extended binding motifs. We speculate that extended
b-TRCP/Slimb binding motifs are likely to be especially
important and prevalent in substrates lacking Gly at the
third position because we found that R333 or R353 (or
both) of Slimb promotes binding to Ci-WT, but not to
Ci-SL, and pS852 contributes significantly to Slimb bind-
ing in Ci-WT, but not in Ci-Y846G.
Vertebrate Gli homologs of Ci also have a residue other
than Gly at the third position (generally Ala) and a poten-
tially phosphorylated Ser at the C terminus of a putative
extended b-TRCP binding motif of 9 to 11 residues
(SSAYx(x)SRRSS). Both a second Wee1A binding motif
(DSAFQEPDS) and a b-TRCP binding motif of the p100
precursor of NFKB p52 (DSAYGSQSVE) also lack a Gly
residue at the third position and include residues beyond
the six amino acid core motif that might, by analogy to Ci,
potentiate binding (Amir et al., 2004; Liang et al., 2006;
Watanabe et al., 2005).
Our studies of Ci provide a clear precedent for the use
of an extended b-TRCP/Slimb binding motif to translate
regulated substrate phosphorylation into regulated prote-
olysis. However, we also found that Slimb binding cannot
be predicted by focusing only on the interactions of
charged residues. Thus, fully phosphorylated Ci includes
two sequences with a distribution of charged residues
similar to that of the primary SCFSlimb binding site
(837DSpQNSpTpASpTp and 858SpSpQVSpSpIPTp com-
pared with 844SpTpYYGSpMQSp), but those sites neither
suffice for Slimb binding (in Ci-S849A) nor enhancevier Inc.
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T842A, S858A, S859A, and Ds2 variants). This probably
reflects significant binding contributions of nonpolar
residues in positions 3–5 of an extended Slimb/b-TRCP
binding motif, as suggested by the presence of Tyr or
Phe at position 4 of the functional motifs of Ci, Gli, p100,
and Wee1A.
Cooperative SCFSlimb Binding via Two
Phosphorylated Regions of Ci and
SCF Oligomerization
Several F-box proteins that use WD40 repeats to bind
substrate (FBW proteins) also include a dimerization
domain that directs assembly of higher-order SCF com-
plexes (Tang et al., 2007; Willems et al., 2004). Some sub-
strates of these SCF complexes (for example, Cyclin E for
Fbw7 and Wee1A for b-TRCP) contain more than one
phosphorylated region capable of interacting with the
same WD40 binding surface of the FBW protein (Hao
et al., 2007; Watanabe et al., 2005). This raises the ques-
tion of whether the cooperative function of two or more
such regions depends on SCF dimerization and simulta-
neous interaction with two FBW subunits of a dimeric
complex.
We found that Ci also contains two phosphorylated
regions that contribute to SCF association and that Slimb
molecules can bind to each other within higher-order
functional SCF complexes. We also found that Slimb
self-association enhanced binding to GST-Ci relative to
GST-Ci-SL, which contains a single DSGxxS motif; how-
ever, it was not required for both phosphorylated regions
of GST-Ci to stimulate binding. Hence, simultaneous bind-
ing to separate Slimb monomers within a larger complex
can be excluded as a requisite mechanism for cooperativ-
ity between the two phosphorylated regions of Ci. This is
consistent with recent structural studies that predict
a wider separation of WD40 binding surfaces within an
SCF dimer than can be spanned readily by the two critical
phosphorylated regions of a single Ci molecule (Tang
et al., 2007).
Does the region preceding PKA site 3 of Ci bind directly
to the FBW component (Slimb) of an SCF complex as for
Cyclin E and Wee1A? That model was proposed for
Gli-2/3 proteins, which include a recognizable, potentially
extended, variant Slimb-binding motif (DSYDPISTDAS)
(Pan et al., 2006; Tempe et al., 2006). The analogously
positioned sequence in Drosophila (SFYDPISPGCS) re-
tains the YDPIS sequence and the two GSK3 sites at
position 7 and 11 (underlined) but lacks a Ser at position
2 (italics), which is required in Gli-2/3 for normal b-TRCP
association and proteolysis. Also, Ala substitution of the
first Ser in the Drosophila motif (together with three other
Ser residues) had only a minor effect on Slimb binding in
vitro and Ci-155 proteolysis in vivo. Thus, this region of
Ci does not have a clearly recognizable and demonstrably
functional, conventional b-TRCP/Slimb binding site. It is,
nevertheless, conceivable that the conserved elements
of the putative b-TRCP binding motif of Gli-2/3 mightDevelopmprovide a very weak direct interaction with the WD40
domain of Slimb that is sufficient to enhance SCFSlimb
association.
However, we also found that the GSK3 enhancement of
Ci-Slimb binding conferred by the GSK3 sites preceding
PKA site 3 was lost if Slimb lacked an F-box domain and
consequent direct association with SkpA and its SCF
complex partners. We interpret this result with some
caution because Slimb-DF also bound less well than
wild-type Slimb to a canonical b-catenin substrate and
to GST-Ci that was phosphorylated only at its primary
Slimb binding site. Nevertheless, the result suggests that
the region of Ci immediately preceding PKA site 3 might
augment SCF association by binding directly to an SCF
component other than Slimb.
Whether GSK3 stimulates Ci binding to SCFSlimb via
a direct interaction with Slimb, an unprecedented interac-
tion with another SCF component, or a conformational
effect on the primary Slimb binding site of Ci, the Ci-G3A
transgene reveals that the stimulation conferred by
GSK3 phosphorylation is critical for efficient Ci-155 prote-
olysis and for Hh pathway silencing (Figure 7). Since Slimb
self-association enhanced GST-Ci, but not GST-Ci-SL,
binding in vitro, we suspect that thismay also be important
for Ci-155 proteolysis in vivo. We do not know if SCFSlimb
dimerization (or oligomerization) is regulated, but the
different modes of association of SCFSlimb with Ci and
b-catenin certainly provide several opportunities for SCF
regulatory mechanisms or mutations to affect the Hh
pathway without altering the Wnt/b-catenin pathway.
EXPERIMENTAL PROCEDURES
Mutagenesis and Cloning
The entry vectors and destination vectors for P-element germline
transformation and tissue culture cell transfection were made using
Gateway Technology (Invitrogen) as described previously (Smelkinson
and Kalderon, 2006). Additionally, for tissue culture cell transfection,
we used destination vectors pAFHW and PAMW, which encode
N-terminal Flag/HA and N-terminal Myc tags, respectively. pGEX2T-
Ci685–920, described previously (Price and Kalderon, 2002), was used
to make the GST-Ci fusion proteins. Mutations were made in
pENTR-D/TOPO-Ci, pENTR-D/TOPO-Slimb, and pGEX2T-Ci using
the QuikChange Site-Directed Mutagenesis Kit (Stratagene), and
altered coding regions were sequenced in their entirety.
Kc Cell Extracts, In Vitro Phosphorylation,
and GST Pull-Down Assay
Cells were cultured as described previously (Smelkinson and Kal-
deron, 2006), but extracts were made 60 hr after providing fresh media
following DNA transfection. In vitro phosphorylation and GST pull-
down assays were described previously (Smelkinson and Kalderon,
2006). Proteins were visualized by western blotting using 12CA5
mouse anti-HA (Jeff Field, University of Pennsylvania), 9E10 mouse
anti-Myc (Developmental Studies Hybridoma Bank [DSHB]), rabbit anti-
Cul1 (Zymed), and rabbit anti-GST primary antibodies. 5923 rabbit
anti-Phospho-S852 (G2) primary antibody was raised and purified by
Quality Controlled Biochemicals as a customized project. Alexa Fluor
680 and 800 (Molecular Probes) were used as secondary antibodies
and visualized using the LI-COROdyssey Infared Imager, which allows
quantification of band intensities after background subtraction, as
described previously (Smelkinson and Kalderon, 2006).ental Cell 13, 481–495, October 2007 ª2007 Elsevier Inc. 493
Developmental Cell
Regulation of Ci Proteolysis by PhosphorylationImmunoprecipitation from Kc Cell Extracts
Ten micrograms of pAFHW-slimb* (Slimb variant with N-terminal Flag/
HA tag) was transfected alone or together with ten micrograms of
pAMW-slimb (Slimb with N-terminal Myc tag). Following lysis, extracts
were incubated with 25 ml bed volume of M2 mouse anti-Flag affinity
agarose gel (Sigma) for approximately 2 hr. Agarose was washed three
times with Kc lysis buffer (Smelkinson and Kalderon, 2006), eluted with
SDS-PAGE loading buffer, and then boiled for 5 min prior to loading.
Immunohistochemistry
Larvae were heat shocked and dissected as described previously
(Smelkinson and Kalderon, 2006). ptc-lacZ and hh-lacZ expression
was assayed using rabbit anti-b-galactosidase antibody (Promega)
and Alexa Fluor 594 or 647 secondary antibodies (Molecular probes),
or according to b-galactosidase activity by incubating wing discs
with X-gal (1X PBS, 0.3% Triton X-100, 1 mM MgCl2, 0.138%
K4Fe(Cn)6, 0.1% K3Fe(Cn)6, 2.4 mg/ml X-gal) for 1 hr at 37
C. Full-
length Ci transgenes were stained with Cy3-conjugated 9E10 mouse
anti-Myc antibody (Amersham) or 9E10 mouse anti-Myc (DSHB) and
Alexa Fluor 594 secondary. En was stained using 4D9 mouse anti-En
(DSHB) and Alexa Fluor 594 secondary. CD2 was stained using mouse
anti-rat CD2 (Serotec) and Alexa Fluor 647 secondary.
Fly crosses can be found in the Supplemental Data.
Supplemental Data
The Supplemental Data for this article, which include fly crosses (Sup-
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